Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8536 to 8550 of 8908 results

  1. Obesity: working with local communities (PH42)

    This guideline has been updated and replaced by NICE guideline NG246.

    Withdrawn guideline

  2. Smoking: brief interventions and referrals (PH1)

    This guidance has been updated and replaced by NICE guideline NG92.

    Withdrawn guideline

  3. Maternal and child nutrition (PH11)

    This guideline has been updated and replaced by NICE guideline NG247.

    Withdrawn guideline

  4. Smoking: preventing uptake in children and young people (PH14)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Withdrawn guideline

  5. HIV testing: increasing uptake in black Africans (PH33)

    This guidance has been updated and replaced by NICE guideline NG60.

    Withdrawn guideline

  6. HIV testing: increasing uptake in men who have sex with men (PH34)

    This guideline has been updated and replaced by NICE guideline NG60.

    Withdrawn guideline

  7. Tuberculosis: identification and management in under-served groups (PH37)

    This guideline has been updated and replaced by NICE guideline NG33.

    Withdrawn guideline

  8. Stop smoking services (PH10)

    This guideline has been updated and replaced by NICE guideline NG92.

    Withdrawn guideline

  9. Social and emotional wellbeing in primary education (PH12)

    This guideline has been updated and replaced by the NICE guideline on social, emotional and mental wellbeing in primary and secondary education (NG223).

    Withdrawn guideline

  10. Lutonix drug-coated balloon for peripheral arterial disease (MIB72)

    NICE withdrew this medtech innovation briefing in October 2019 after the MHRA withdrew support for this type of technology being used in intermittent claudication for arterial disease.

    Withdrawn advice

  11. Ultroid 2.0 for internal haemorrhoids (MIB75)

    This medtech innovation briefing is temporarily unavailable, please contact mibs@nice.org.uk for further information.

    Withdrawn advice

  12. Endoluminal gastroplication for gastro-oesophageal reflux disease (IPG404)

    Interventional procedures, IPG404 - Issued: July 2011 --> This guidance has been updated and replaced by NICE HealthTech guidance 661.

    Withdrawn guidance

  13. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension (IPG418)

    Interventional procedures, IPG418 - Issued: January 2012 --> This guidance has been updated and replaced by NICE HealthTech guidance 662.

    Withdrawn guidance

  14. Xpert MTB/RIF assay for the detection of active pulmonary tuberculosis and multi-drug resistant tuberculosis

    Discontinued Reference number: GID-DT9

    Diagnostics guidance
    Discontinued

  15. Secukinumab for treating enthesitis-related arthritis or juvenile psoriatic arthritis [ID3738]

    Discontinued Reference number: GID-TA10598

    Technology appraisal guidance
    Discontinued